Tolvaptan for paraneoplastic SIADH in small cell lung cancer: a scoping review.

Cammann VL, Sheryl M, Fürst T, Jehle AW

DOI: 10.1016/j.ctarc.2026.101233
Published: 2026
Container: Cancer treatment and research communications
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ctarc.2026.101233,
  title = {Tolvaptan for paraneoplastic SIADH in small cell lung cancer: a scoping review.},
  author = {Cammann VL and Sheryl M and Fürst T and Jehle AW},
  year = {2026},
  journal = {Cancer treatment and research communications},
  doi = {10.1016/j.ctarc.2026.101233},
  url = {https://doi.org/10.1016/j.ctarc.2026.101233}
}

RIS

TY  - JOUR
TI  - Tolvaptan for paraneoplastic SIADH in small cell lung cancer: a scoping review.
AU  - Cammann VL
AU  - Sheryl M
AU  - Fürst T
AU  - Jehle AW
PY  - 2026
JO  - Cancer treatment and research communications
DO  - 10.1016/j.ctarc.2026.101233
UR  - https://doi.org/10.1016/j.ctarc.2026.101233
ER  -

APA

VL, C., M, S., T, F., & AW, J. (2026). Tolvaptan for paraneoplastic SIADH in small cell lung cancer: a scoping review.. Cancer treatment and research communications. https://doi.org/10.1016/j.ctarc.2026.101233

Source records

pubmed · retrieved 2026-09-26T13:10:28.498Z